Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hematopoietic Stem Cell Transplantation | 86 | 2024 | 5672 | 5.820 |
Why?
|
Graft vs Host Disease | 32 | 2024 | 3029 | 2.570 |
Why?
|
Hepatic Veno-Occlusive Disease | 5 | 2022 | 220 | 1.750 |
Why?
|
Adrenoleukodystrophy | 7 | 2024 | 143 | 1.550 |
Why?
|
Thrombotic Microangiopathies | 4 | 2021 | 123 | 1.510 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 5 | 2021 | 269 | 1.010 |
Why?
|
Transplantation Conditioning | 14 | 2022 | 1590 | 0.820 |
Why?
|
Lysosomal Storage Diseases | 1 | 2022 | 79 | 0.780 |
Why?
|
Bronchiolitis Obliterans | 3 | 2019 | 213 | 0.720 |
Why?
|
Hematologic Neoplasms | 4 | 2024 | 1896 | 0.690 |
Why?
|
Sunlight | 2 | 2019 | 337 | 0.660 |
Why?
|
Child | 73 | 2024 | 80158 | 0.630 |
Why?
|
Transplantation, Homologous | 20 | 2024 | 4807 | 0.620 |
Why?
|
Stomatitis | 2 | 2023 | 271 | 0.620 |
Why?
|
Sunburn | 1 | 2019 | 156 | 0.610 |
Why?
|
Lentivirus | 3 | 2024 | 508 | 0.500 |
Why?
|
Anemia, Aplastic | 4 | 2020 | 230 | 0.480 |
Why?
|
Skin Diseases | 4 | 2019 | 1094 | 0.480 |
Why?
|
Leukemia, Myeloid, Acute | 4 | 2021 | 3615 | 0.470 |
Why?
|
Child, Preschool | 36 | 2024 | 42232 | 0.470 |
Why?
|
Myeloablative Agonists | 1 | 2014 | 209 | 0.450 |
Why?
|
Leukemia | 3 | 2022 | 1522 | 0.440 |
Why?
|
Soaps | 1 | 2013 | 29 | 0.440 |
Why?
|
Bleomycin | 1 | 2014 | 494 | 0.430 |
Why?
|
Skin Care | 1 | 2013 | 57 | 0.420 |
Why?
|
Survivors | 7 | 2024 | 2371 | 0.420 |
Why?
|
Surface-Active Agents | 1 | 2013 | 150 | 0.410 |
Why?
|
Nervous System Diseases | 2 | 2022 | 1667 | 0.400 |
Why?
|
Myelodysplastic Syndromes | 4 | 2024 | 1394 | 0.390 |
Why?
|
Adolescent | 46 | 2024 | 88326 | 0.390 |
Why?
|
Acute Lung Injury | 3 | 2022 | 367 | 0.380 |
Why?
|
Infant | 28 | 2024 | 36193 | 0.380 |
Why?
|
Respiratory Insufficiency | 5 | 2022 | 1230 | 0.380 |
Why?
|
Bone Marrow Diseases | 3 | 2017 | 233 | 0.360 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2014 | 678 | 0.350 |
Why?
|
Cardiotonic Agents | 1 | 2013 | 539 | 0.340 |
Why?
|
Vasoconstrictor Agents | 1 | 2013 | 654 | 0.330 |
Why?
|
Combined Modality Therapy | 3 | 2018 | 8527 | 0.320 |
Why?
|
Genetic Vectors | 3 | 2024 | 3396 | 0.310 |
Why?
|
Transplantation, Autologous | 4 | 2022 | 2115 | 0.310 |
Why?
|
Vasodilator Agents | 1 | 2013 | 973 | 0.310 |
Why?
|
Pravastatin | 1 | 2010 | 392 | 0.300 |
Why?
|
Continuous Positive Airway Pressure | 1 | 2013 | 575 | 0.300 |
Why?
|
Health Behavior | 1 | 2019 | 2644 | 0.290 |
Why?
|
Humans | 109 | 2024 | 761596 | 0.290 |
Why?
|
Hemoglobinopathies | 2 | 2018 | 99 | 0.270 |
Why?
|
Young Adult | 28 | 2024 | 59260 | 0.270 |
Why?
|
Hemoglobinuria, Paroxysmal | 2 | 2017 | 94 | 0.270 |
Why?
|
Respiration, Artificial | 7 | 2024 | 2630 | 0.270 |
Why?
|
Polydeoxyribonucleotides | 3 | 2022 | 136 | 0.260 |
Why?
|
Dopamine | 1 | 2013 | 1607 | 0.250 |
Why?
|
Lung Diseases | 2 | 2019 | 1909 | 0.250 |
Why?
|
Interleukin-2 | 2 | 2023 | 1889 | 0.240 |
Why?
|
Retrospective Studies | 28 | 2024 | 80647 | 0.240 |
Why?
|
Male | 56 | 2024 | 360846 | 0.240 |
Why?
|
Severe Combined Immunodeficiency | 2 | 2017 | 227 | 0.230 |
Why?
|
Down Syndrome | 1 | 2012 | 901 | 0.230 |
Why?
|
Neoplasms, Second Primary | 3 | 2017 | 1052 | 0.220 |
Why?
|
Female | 54 | 2024 | 392705 | 0.220 |
Why?
|
Jaundice, Neonatal | 1 | 2003 | 71 | 0.210 |
Why?
|
Anticholesteremic Agents | 1 | 2010 | 966 | 0.210 |
Why?
|
Bites and Stings | 1 | 2003 | 93 | 0.210 |
Why?
|
Skin Neoplasms | 2 | 2019 | 5821 | 0.210 |
Why?
|
Disease-Free Survival | 4 | 2024 | 6815 | 0.200 |
Why?
|
Neoplasms | 8 | 2024 | 22173 | 0.200 |
Why?
|
Survival Rate | 6 | 2024 | 12723 | 0.200 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2024 | 755 | 0.200 |
Why?
|
Risk Factors | 19 | 2024 | 74213 | 0.200 |
Why?
|
Mouth Diseases | 1 | 2024 | 241 | 0.190 |
Why?
|
Chronic Disease | 9 | 2024 | 9319 | 0.190 |
Why?
|
Vitamin D Deficiency | 1 | 2010 | 1388 | 0.180 |
Why?
|
Extracorporeal Membrane Oxygenation | 2 | 2022 | 1462 | 0.180 |
Why?
|
Age Factors | 8 | 2021 | 18399 | 0.170 |
Why?
|
Immunotherapy | 5 | 2023 | 4652 | 0.170 |
Why?
|
Biopsy | 2 | 2014 | 6766 | 0.170 |
Why?
|
Immunotherapy, Adoptive | 2 | 2021 | 1469 | 0.170 |
Why?
|
Tracheostomy | 1 | 2024 | 426 | 0.170 |
Why?
|
Intubation | 1 | 2020 | 139 | 0.170 |
Why?
|
Dyskeratosis Congenita | 2 | 2017 | 73 | 0.170 |
Why?
|
Vitiligo | 2 | 2018 | 97 | 0.170 |
Why?
|
Cardiovascular Diseases | 4 | 2018 | 15502 | 0.170 |
Why?
|
Lung Injury | 1 | 2024 | 422 | 0.170 |
Why?
|
Anemia, Diamond-Blackfan | 2 | 2017 | 138 | 0.160 |
Why?
|
Skin | 1 | 2013 | 4484 | 0.160 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2019 | 61 | 0.160 |
Why?
|
Multiple Organ Failure | 2 | 2019 | 387 | 0.160 |
Why?
|
Follow-Up Studies | 10 | 2024 | 39106 | 0.160 |
Why?
|
Critical Illness | 4 | 2022 | 2723 | 0.160 |
Why?
|
Intensive Care Units, Pediatric | 4 | 2020 | 1017 | 0.160 |
Why?
|
Vascular Diseases | 2 | 2017 | 1161 | 0.160 |
Why?
|
Complement Inactivating Agents | 1 | 2019 | 53 | 0.160 |
Why?
|
Chest Wall Oscillation | 1 | 2017 | 15 | 0.150 |
Why?
|
Fanconi Anemia | 2 | 2017 | 324 | 0.150 |
Why?
|
Nail Diseases | 1 | 2018 | 55 | 0.150 |
Why?
|
Heart Atria | 1 | 2023 | 1345 | 0.140 |
Why?
|
Postoperative Complications | 5 | 2024 | 15633 | 0.140 |
Why?
|
Epstein-Barr Virus Infections | 1 | 2023 | 612 | 0.140 |
Why?
|
Vitamin D | 1 | 2010 | 3303 | 0.140 |
Why?
|
Brain | 3 | 2024 | 27121 | 0.130 |
Why?
|
Thalassemia | 1 | 2017 | 267 | 0.130 |
Why?
|
Adult | 23 | 2024 | 221210 | 0.130 |
Why?
|
GATA2 Transcription Factor | 1 | 2016 | 158 | 0.130 |
Why?
|
Neonatal Screening | 1 | 2020 | 597 | 0.130 |
Why?
|
Sepsis | 2 | 2022 | 2585 | 0.130 |
Why?
|
Fungi | 2 | 2020 | 338 | 0.130 |
Why?
|
Donor Selection | 1 | 2017 | 232 | 0.130 |
Why?
|
Liver | 1 | 2011 | 7528 | 0.120 |
Why?
|
Treatment Outcome | 13 | 2024 | 64685 | 0.120 |
Why?
|
Severity of Illness Index | 5 | 2021 | 15843 | 0.120 |
Why?
|
Hematopoietic Stem Cells | 3 | 2023 | 3397 | 0.120 |
Why?
|
Nevus, Pigmented | 1 | 2017 | 222 | 0.120 |
Why?
|
Central Nervous System Diseases | 1 | 2019 | 520 | 0.120 |
Why?
|
Bilirubin | 2 | 2019 | 436 | 0.120 |
Why?
|
Practice Guidelines as Topic | 6 | 2024 | 7391 | 0.120 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 226 | 0.120 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2017 | 563 | 0.120 |
Why?
|
Length of Stay | 4 | 2018 | 6426 | 0.110 |
Why?
|
Haploinsufficiency | 1 | 2016 | 337 | 0.110 |
Why?
|
Uterine Hemorrhage | 1 | 2015 | 240 | 0.110 |
Why?
|
Clinical Nursing Research | 1 | 2013 | 14 | 0.110 |
Why?
|
Leukodystrophy, Metachromatic | 1 | 2014 | 44 | 0.110 |
Why?
|
Alopecia | 1 | 2018 | 412 | 0.110 |
Why?
|
Survival Analysis | 5 | 2021 | 10090 | 0.110 |
Why?
|
Intubation, Intratracheal | 2 | 2018 | 1333 | 0.110 |
Why?
|
Maximum Tolerated Dose | 2 | 2019 | 883 | 0.110 |
Why?
|
Pilot Projects | 3 | 2022 | 8633 | 0.100 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2016 | 547 | 0.100 |
Why?
|
Bacterial Load | 1 | 2013 | 152 | 0.100 |
Why?
|
Osteonecrosis | 1 | 2014 | 229 | 0.100 |
Why?
|
Nails | 1 | 2014 | 296 | 0.100 |
Why?
|
Physical Therapy Modalities | 1 | 2016 | 532 | 0.100 |
Why?
|
Psoriasis | 2 | 2018 | 950 | 0.100 |
Why?
|
Respiratory Tract Infections | 1 | 2020 | 1010 | 0.100 |
Why?
|
Amenorrhea | 1 | 2015 | 483 | 0.100 |
Why?
|
Pediatrics | 3 | 2021 | 3589 | 0.090 |
Why?
|
Research | 2 | 2017 | 1982 | 0.090 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2019 | 1551 | 0.090 |
Why?
|
Infant, Newborn | 8 | 2024 | 26202 | 0.090 |
Why?
|
Busulfan | 2 | 2022 | 258 | 0.090 |
Why?
|
Vaccination | 1 | 2003 | 3384 | 0.090 |
Why?
|
Running | 2 | 2006 | 488 | 0.090 |
Why?
|
Melphalan | 2 | 2023 | 420 | 0.090 |
Why?
|
Neuroblastoma | 1 | 2019 | 1250 | 0.090 |
Why?
|
Recurrence | 3 | 2022 | 8466 | 0.090 |
Why?
|
Edema | 1 | 2014 | 766 | 0.090 |
Why?
|
Mycoses | 1 | 2013 | 386 | 0.090 |
Why?
|
Cross-Sectional Studies | 4 | 2019 | 26129 | 0.090 |
Why?
|
Eosinophilia | 1 | 2014 | 560 | 0.080 |
Why?
|
Time Factors | 6 | 2018 | 39969 | 0.080 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 2015 | 1148 | 0.080 |
Why?
|
Databases, Factual | 6 | 2024 | 7968 | 0.080 |
Why?
|
Patient Selection | 1 | 2021 | 4244 | 0.080 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2011 | 412 | 0.080 |
Why?
|
Incidence | 5 | 2021 | 21355 | 0.080 |
Why?
|
Patient Education as Topic | 1 | 2019 | 2319 | 0.080 |
Why?
|
Poverty | 1 | 2021 | 2697 | 0.080 |
Why?
|
Immunosuppressive Agents | 3 | 2021 | 4176 | 0.080 |
Why?
|
Cataract | 1 | 2014 | 832 | 0.080 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2013 | 2496 | 0.080 |
Why?
|
Pyrazoles | 1 | 2019 | 2009 | 0.080 |
Why?
|
Cytomegalovirus Infections | 1 | 2015 | 831 | 0.080 |
Why?
|
Viscera | 1 | 2008 | 138 | 0.080 |
Why?
|
Anemia, Sickle Cell | 1 | 2017 | 1063 | 0.080 |
Why?
|
Creatine Kinase | 1 | 2010 | 685 | 0.070 |
Why?
|
Herpesvirus 3, Human | 1 | 2008 | 159 | 0.070 |
Why?
|
Antifungal Agents | 1 | 2012 | 753 | 0.070 |
Why?
|
Alanine Transaminase | 1 | 2010 | 603 | 0.070 |
Why?
|
Genetic Testing | 1 | 2020 | 3537 | 0.070 |
Why?
|
Fever | 1 | 2015 | 1618 | 0.070 |
Why?
|
Recovery of Function | 1 | 2017 | 2979 | 0.070 |
Why?
|
Liver Diseases | 2 | 2017 | 1297 | 0.070 |
Why?
|
Drug Interactions | 1 | 2011 | 1416 | 0.070 |
Why?
|
Cross-Over Studies | 1 | 2013 | 2079 | 0.070 |
Why?
|
Mouth Mucosa | 2 | 2024 | 432 | 0.070 |
Why?
|
Preoperative Care | 1 | 2015 | 2242 | 0.070 |
Why?
|
Critical Care | 4 | 2024 | 2697 | 0.070 |
Why?
|
Herpes Zoster | 1 | 2008 | 253 | 0.070 |
Why?
|
Graft Survival | 1 | 2017 | 3820 | 0.070 |
Why?
|
Opportunistic Infections | 1 | 2008 | 376 | 0.060 |
Why?
|
Mass Screening | 3 | 2018 | 5429 | 0.060 |
Why?
|
Disease Management | 4 | 2017 | 2508 | 0.060 |
Why?
|
Vital Capacity | 1 | 2008 | 971 | 0.060 |
Why?
|
Feasibility Studies | 1 | 2016 | 5247 | 0.060 |
Why?
|
Consensus | 3 | 2021 | 3124 | 0.060 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2019 | 2422 | 0.060 |
Why?
|
Proteome | 1 | 2014 | 1862 | 0.060 |
Why?
|
Bone Marrow | 1 | 2014 | 2911 | 0.060 |
Why?
|
Cohort Studies | 5 | 2021 | 41495 | 0.060 |
Why?
|
Parathyroid Hormone | 1 | 2010 | 1803 | 0.060 |
Why?
|
Logistic Models | 3 | 2017 | 13255 | 0.060 |
Why?
|
Rabies Vaccines | 1 | 2003 | 27 | 0.060 |
Why?
|
Survival | 1 | 2024 | 161 | 0.060 |
Why?
|
Chemokine CXCL9 | 1 | 2023 | 135 | 0.050 |
Why?
|
Adrenal Cortex Hormones | 1 | 2012 | 1881 | 0.050 |
Why?
|
Rabies | 1 | 2003 | 54 | 0.050 |
Why?
|
Respiratory Function Tests | 1 | 2008 | 1682 | 0.050 |
Why?
|
Smallpox Vaccine | 1 | 2003 | 77 | 0.050 |
Why?
|
Liver Transplantation | 1 | 2014 | 2330 | 0.050 |
Why?
|
Forced Expiratory Volume | 1 | 2008 | 1814 | 0.050 |
Why?
|
Prospective Studies | 4 | 2021 | 54423 | 0.050 |
Why?
|
Hyponatremia | 1 | 2005 | 279 | 0.050 |
Why?
|
Decontamination | 1 | 2022 | 73 | 0.050 |
Why?
|
Thiotepa | 1 | 2021 | 66 | 0.050 |
Why?
|
Psoas Abscess | 1 | 2001 | 10 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2020 | 9280 | 0.050 |
Why?
|
Middle Aged | 9 | 2024 | 220921 | 0.050 |
Why?
|
Whole-Body Irradiation | 1 | 2022 | 433 | 0.050 |
Why?
|
Anthracyclines | 1 | 2023 | 284 | 0.050 |
Why?
|
Proteomics | 1 | 2014 | 3848 | 0.050 |
Why?
|
Aneurysm, Infected | 1 | 2001 | 82 | 0.050 |
Why?
|
Tissue Donors | 2 | 2023 | 2332 | 0.050 |
Why?
|
Aged | 9 | 2024 | 169310 | 0.040 |
Why?
|
Patient Readmission | 1 | 2015 | 3271 | 0.040 |
Why?
|
Fatal Outcome | 2 | 2019 | 1835 | 0.040 |
Why?
|
Vidarabine | 1 | 2021 | 336 | 0.040 |
Why?
|
Cholagogues and Choleretics | 1 | 2019 | 39 | 0.040 |
Why?
|
Ursodeoxycholic Acid | 1 | 2019 | 81 | 0.040 |
Why?
|
Intensive Care Units | 1 | 2013 | 3744 | 0.040 |
Why?
|
Heparin | 1 | 2006 | 1634 | 0.040 |
Why?
|
Inflammation | 1 | 2019 | 10774 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2012 | 13642 | 0.040 |
Why?
|
Water | 1 | 2005 | 1411 | 0.040 |
Why?
|
Thrombocytopenia | 1 | 2006 | 1182 | 0.040 |
Why?
|
Obesity | 2 | 2018 | 12947 | 0.040 |
Why?
|
Dogs | 1 | 2003 | 3839 | 0.040 |
Why?
|
Adrenal Insufficiency | 1 | 2020 | 194 | 0.040 |
Why?
|
Monte Carlo Method | 1 | 2023 | 1258 | 0.040 |
Why?
|
Radiometry | 1 | 2023 | 813 | 0.040 |
Why?
|
Cyclosporine | 1 | 2021 | 778 | 0.040 |
Why?
|
Longitudinal Studies | 1 | 2014 | 14608 | 0.040 |
Why?
|
Herpesvirus 4, Human | 1 | 2023 | 1078 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2010 | 3415 | 0.040 |
Why?
|
Ultrasonography, Doppler | 1 | 2019 | 462 | 0.040 |
Why?
|
Tacrolimus | 1 | 2021 | 733 | 0.040 |
Why?
|
Asthma | 1 | 2016 | 6234 | 0.040 |
Why?
|
Neurotoxicity Syndromes | 1 | 2021 | 301 | 0.030 |
Why?
|
Fibrosis | 1 | 2024 | 2049 | 0.030 |
Why?
|
Electrolytes | 1 | 2017 | 274 | 0.030 |
Why?
|
Biomedical Research | 2 | 2017 | 3429 | 0.030 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2017 | 168 | 0.030 |
Why?
|
Aortic Aneurysm | 1 | 2001 | 648 | 0.030 |
Why?
|
Catheterization, Central Venous | 1 | 2001 | 526 | 0.030 |
Why?
|
Viruses | 1 | 2020 | 375 | 0.030 |
Why?
|
Health Planning Guidelines | 1 | 2016 | 151 | 0.030 |
Why?
|
Paracentesis | 1 | 2016 | 98 | 0.030 |
Why?
|
Cryopreservation | 1 | 2021 | 728 | 0.030 |
Why?
|
Cyclophosphamide | 1 | 2021 | 2220 | 0.030 |
Why?
|
Ascites | 1 | 2017 | 338 | 0.030 |
Why?
|
Infant, Premature, Diseases | 1 | 2001 | 710 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 2017 | 658 | 0.030 |
Why?
|
Goserelin | 1 | 2015 | 126 | 0.030 |
Why?
|
Methylococcaceae | 1 | 1994 | 4 | 0.030 |
Why?
|
Cytochromes | 1 | 1994 | 18 | 0.030 |
Why?
|
Breast Feeding | 1 | 2003 | 1360 | 0.030 |
Why?
|
Respiratory Rate | 1 | 2016 | 176 | 0.030 |
Why?
|
Hydroxylamines | 1 | 1994 | 40 | 0.030 |
Why?
|
Histiocytosis | 1 | 2014 | 39 | 0.030 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2017 | 629 | 0.030 |
Why?
|
Weight Gain | 1 | 2005 | 2348 | 0.030 |
Why?
|
Body Fluids | 1 | 2016 | 320 | 0.030 |
Why?
|
Hospitals, Pediatric | 1 | 2024 | 1860 | 0.030 |
Why?
|
Manikins | 1 | 2016 | 244 | 0.030 |
Why?
|
Contraceptive Agents, Female | 1 | 2015 | 118 | 0.030 |
Why?
|
Nitrites | 1 | 1994 | 159 | 0.030 |
Why?
|
Methotrexate | 1 | 2021 | 1719 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2006 | 5112 | 0.030 |
Why?
|
Tidal Volume | 1 | 2016 | 488 | 0.030 |
Why?
|
Leuprolide | 1 | 2015 | 312 | 0.030 |
Why?
|
Age of Onset | 1 | 2021 | 3306 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2021 | 2693 | 0.030 |
Why?
|
Platelet Count | 1 | 2016 | 781 | 0.030 |
Why?
|
Nitriles | 1 | 2019 | 971 | 0.030 |
Why?
|
Prevalence | 1 | 2010 | 15733 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2397 | 0.030 |
Why?
|
Siblings | 1 | 2017 | 825 | 0.030 |
Why?
|
Diuretics | 1 | 2016 | 610 | 0.030 |
Why?
|
Heart Transplantation | 1 | 2006 | 3233 | 0.030 |
Why?
|
Granulocytes | 1 | 2014 | 551 | 0.030 |
Why?
|
Candidiasis, Oral | 1 | 2012 | 57 | 0.030 |
Why?
|
Morbidity | 1 | 2017 | 1752 | 0.020 |
Why?
|
Transplantation Chimera | 1 | 2014 | 594 | 0.020 |
Why?
|
T-Lymphocytes | 2 | 2021 | 10194 | 0.020 |
Why?
|
Kinetics | 1 | 2019 | 6374 | 0.020 |
Why?
|
Immunologic Factors | 1 | 2021 | 1590 | 0.020 |
Why?
|
Guidelines as Topic | 1 | 2018 | 1386 | 0.020 |
Why?
|
Resuscitation | 1 | 2016 | 673 | 0.020 |
Why?
|
Lung | 2 | 2024 | 10002 | 0.020 |
Why?
|
Central Nervous System | 1 | 2018 | 1336 | 0.020 |
Why?
|
Sarcopenia | 1 | 2016 | 372 | 0.020 |
Why?
|
Salivary Glands | 1 | 2012 | 229 | 0.020 |
Why?
|
Anticoagulants | 1 | 2006 | 4812 | 0.020 |
Why?
|
Acute Disease | 1 | 2021 | 7237 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1858 | 0.020 |
Why?
|
United States | 3 | 2024 | 72340 | 0.020 |
Why?
|
International Cooperation | 1 | 2017 | 1422 | 0.020 |
Why?
|
Hematologic Diseases | 1 | 2014 | 496 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2019 | 2201 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3683 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2016 | 1440 | 0.020 |
Why?
|
Organ Specificity | 1 | 2015 | 1968 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2019 | 2084 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2024 | 3206 | 0.020 |
Why?
|
Mouth | 1 | 2012 | 381 | 0.020 |
Why?
|
Societies, Medical | 1 | 2021 | 3905 | 0.020 |
Why?
|
Insurance Coverage | 1 | 2021 | 1940 | 0.020 |
Why?
|
Bacteria | 1 | 2020 | 2199 | 0.020 |
Why?
|
Dyslipidemias | 1 | 2016 | 868 | 0.020 |
Why?
|
Sex Factors | 2 | 2017 | 10554 | 0.020 |
Why?
|
Gastrointestinal Tract | 1 | 2014 | 833 | 0.020 |
Why?
|
Dental Caries | 1 | 2012 | 427 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2017 | 22176 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6075 | 0.020 |
Why?
|
Acyclovir | 1 | 2008 | 268 | 0.020 |
Why?
|
Prognosis | 2 | 2020 | 29629 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2016 | 1376 | 0.020 |
Why?
|
Forecasting | 1 | 2017 | 2928 | 0.020 |
Why?
|
Medicaid | 1 | 2021 | 2818 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2022 | 12463 | 0.020 |
Why?
|
Body Mass Index | 1 | 2005 | 12953 | 0.020 |
Why?
|
Lymphocytes | 1 | 2014 | 2612 | 0.020 |
Why?
|
Virus Activation | 1 | 2008 | 322 | 0.020 |
Why?
|
Neutrophils | 1 | 2019 | 3767 | 0.020 |
Why?
|
Autoimmunity | 1 | 2014 | 1356 | 0.020 |
Why?
|
Pyrimidines | 1 | 2019 | 3028 | 0.020 |
Why?
|
Kidney Diseases | 1 | 2017 | 2091 | 0.020 |
Why?
|
Internship and Residency | 1 | 2006 | 5882 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2019 | 3080 | 0.020 |
Why?
|
Hirudins | 1 | 2006 | 179 | 0.020 |
Why?
|
Odds Ratio | 1 | 2017 | 9647 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2012 | 4853 | 0.010 |
Why?
|
Thrombin | 1 | 2006 | 591 | 0.010 |
Why?
|
Drinking | 1 | 2005 | 198 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2019 | 10451 | 0.010 |
Why?
|
Urine | 1 | 2005 | 362 | 0.010 |
Why?
|
Epilepsy | 1 | 2019 | 3290 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2017 | 4758 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8225 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2018 | 12973 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 2017 | 4235 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2016 | 5293 | 0.010 |
Why?
|
Disease Progression | 1 | 2019 | 13510 | 0.010 |
Why?
|
Cardiopulmonary Bypass | 1 | 2006 | 1092 | 0.010 |
Why?
|
Retroperitoneal Space | 1 | 2001 | 170 | 0.010 |
Why?
|
Animals | 2 | 2022 | 168475 | 0.010 |
Why?
|
Sodium | 1 | 2005 | 1588 | 0.010 |
Why?
|
Beverages | 1 | 2005 | 821 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5337 | 0.010 |
Why?
|
Catheterization, Peripheral | 1 | 2001 | 343 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2024 | 36426 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6534 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2005 | 6228 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2008 | 3060 | 0.010 |
Why?
|
Quality of Life | 1 | 2017 | 13367 | 0.010 |
Why?
|
Hydroxylamine | 1 | 1994 | 16 | 0.010 |
Why?
|
Isoelectric Point | 1 | 1994 | 76 | 0.010 |
Why?
|
Mice | 1 | 2022 | 81539 | 0.010 |
Why?
|
Methane | 1 | 1994 | 52 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2011 | 10212 | 0.010 |
Why?
|
Electron Spin Resonance Spectroscopy | 1 | 1994 | 162 | 0.010 |
Why?
|
Spectrophotometry | 1 | 1994 | 309 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2006 | 10766 | 0.010 |
Why?
|
Electron Transport | 1 | 1994 | 210 | 0.010 |
Why?
|
Ammonia | 1 | 1994 | 237 | 0.010 |
Why?
|
Boston | 1 | 2006 | 9327 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 58984 | 0.010 |
Why?
|
Heme | 1 | 1994 | 313 | 0.010 |
Why?
|
Thrombosis | 1 | 2006 | 2942 | 0.010 |
Why?
|
Molecular Weight | 1 | 1994 | 2186 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 2001 | 1407 | 0.010 |
Why?
|
Infant, Premature | 1 | 2001 | 2107 | 0.010 |
Why?
|
Pregnancy | 1 | 2012 | 29890 | 0.010 |
Why?
|
Metals | 1 | 1994 | 719 | 0.010 |
Why?
|
Amino Acids | 1 | 1994 | 1718 | 0.000 |
Why?
|
Ultrasonography | 1 | 2001 | 5971 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1994 | 13446 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1994 | 17635 | 0.000 |
Why?
|